Physician profile
Eric David Pinnar
NPI 1700977709
$4,035.19
in general payments reported to CMS, 2019-2025
10 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.24 · 2020: $160 · 2021: $2,930 · 2022: $217 · 2023: $179 · 2024: $105 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $3,140.06 | 2021-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $499.99 | 2020-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Reshape Lifesciences INC. | $138.53 | 2022 | |
| Tela Bio, INC. | $63.65 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $51.01 | 2025 | Progrip |
| Olympus America INC. | $44.93 | 2020-2021 | |
| Lsi Solutions INC | $28.42 | 2022 | |
| Abbvie INC. | $26.82 | 2024 | |
| Ethicon US, LLC | $21.24 | 2019 | |
| Organogenesis INC. | $20.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pinnar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.